{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T11:00:57Z","timestamp":1794135657036,"version":"4.8.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The rise of multidrug-resistant and persister cell populations of\n                    <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                    (\n                    <jats:italic>A. baumannii<\/jats:italic>\n                    ) poses a significant threat in healthcare settings, highlighting the need for novel therapeutic strategies. This study investigates a specifically designed antimicrobial peptide and its potential activity against this pathogen. Using advanced bioinformatics, a 20-amino acid antimicrobial peptide was designed and synthesized. The peptide\u2019s efficacy was evaluated in vitro through MIC assays against\n                    <jats:italic>A. baumannii<\/jats:italic>\n                    , along with assessments of its effects on persister cells, biofilm formation, and gene expression (pmrB and lasI) using quantitative PCR. The designed peptide exhibited a potent MIC value of 64 \u00b5g\/mL, reducing persister cell populations of\n                    <jats:italic>A. baumannii<\/jats:italic>\n                    by 75% within 24 h (p\u2009&lt;\u20090.0001). It significantly inhibited biofilm formation, with OD reductions of up to 5.4 log at 64 \u00b5g\/mL (p\u2009&lt;\u20090.0001). Real-time PCR analysis revealed a 6.2-fold upregulation of pmrB and 3.7-fold upregulation of lasI after 24 h (p\u2009&lt;\u20090.0001), indicating bacterial adaptive responses. The antimicrobial peptide demonstrated strong antibacterial and antibiofilm activity against\n                    <jats:italic>A. baumannii<\/jats:italic>\n                    , though with moderate cytotoxicity (8\u201317% reduction in cell viability). These findings suggest a promising avenue for developing novel antimicrobial strategies.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-33137-w","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T23:04:43Z","timestamp":1766790283000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["In vitro assessment of an antimicrobial peptide against Acinetobacter baumannii persister cells"],"prefix":"10.1038","volume":"16","author":[{"given":"Mandana","family":"Hosseini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzaneh","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour","family":"Amirmozafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas Akhavan","family":"Sepahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"key":"33137_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11033-024-10156-w","volume":"52","author":"SM Shamsoddini","year":"2024","unstructured":"Shamsoddini, S. M., Davoudi, M., Shahbazi, S. & Karizi, S. Z. Green synthesis of silver nanoparticles using acroptilon repens aqueous extract and their antibacterial efficacy against multidrug-resistant Acinetobacter baumannii. Mol. Biol. Rep. 52, 47. https:\/\/doi.org\/10.1007\/s11033-024-10156-w (2024).","journal-title":"Mol. Biol. Rep."},{"key":"33137_CR2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01063-24","author":"CJ Kubin","year":"2025","unstructured":"Kubin, C. J., Garzia, C. & Uhlemann, A. C. Acinetobacter baumannii treatment strategies: a review of therapeutic challenges and considerations. Antimicrob. Agents Chemother. https:\/\/doi.org\/10.1128\/aac.01063-24 (2025).","journal-title":"Antimicrob. Agents Chemother."},{"key":"33137_CR3","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1080\/14787210.2023.2256975","volume":"21","author":"R Chegene Lorestani","year":"2023","unstructured":"Chegene Lorestani, R., Shojaeian, A. & Rostamian, M. Phenotypic, genotypic, and metabolic resistance mechanisms of ESKAPE bacteria to chemical disinfectants: a systematic review and meta-analysis. Expert Rev. Anti Infect. Ther. 21, 1097\u20131123 (2023).","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"33137_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/pathogens10030373","volume":"10","author":"I Kyriakidis","year":"2021","unstructured":"Kyriakidis, I., Vasileiou, E., Pana, Z. D. & Tragiannidis, A. Acinetobacter baumannii antibiotic resistance mechanisms. Pathogens 10, 373 (2021).","journal-title":"Pathogens"},{"key":"33137_CR5","doi-asserted-by":"publisher","first-page":"126722","DOI":"10.1016\/j.micres.2021.126722","volume":"247","author":"HJ Mea","year":"2021","unstructured":"Mea, H. J., Yong, P. V. C. & Wong, E. H. An overview of Acinetobacter baumannii pathogenesis: Motility, adherence and biofilm formation. Microbiol. Res. 247, 126722 (2021).","journal-title":"Microbiol. Res."},{"key":"33137_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nrmicro.2017.148","volume":"16","author":"CM Harding","year":"2018","unstructured":"Harding, C. M., Hennon, S. W. & Feldman, M. F. Uncovering the mechanisms of Acinetobacter baumannii virulence. Nat. Rev. Microbiol. 16, 91\u2013102 (2018).","journal-title":"Nat. Rev. Microbiol."},{"key":"33137_CR7","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s00203-025-04394-0","volume":"207","author":"A Sahu","year":"2025","unstructured":"Sahu, A., Jain, S., Junghare, M., Mishra, A. & Ruhal, R. Biofilm-dispersal patterns in ESKAPE pathogens. Arch. Microbiol. 207, 194 (2025).","journal-title":"Arch. Microbiol."},{"key":"33137_CR8","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrmicro.2017.42","volume":"15","author":"RA Fisher","year":"2017","unstructured":"Fisher, R. A., Gollan, B. & Helaine, S. Persistent bacterial infections and persister cells. Nat. Rev. Microbiol. 15, 453\u2013464 (2017).","journal-title":"Nat. Rev. Microbiol."},{"key":"33137_CR9","doi-asserted-by":"crossref","unstructured":"Mortensen, B. L. & Skaar, E. P. The contribution of nutrient metal acquisition and metabolism to Acinetobacter baumannii survival within the host. Front Cell. Infect. Microbiol. 3 (2013).","DOI":"10.3389\/fcimb.2013.00095"},{"key":"33137_CR10","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2174\/0929866529666220613102145","volume":"29","author":"R Zhang","year":"2022","unstructured":"Zhang, R., Xu, L. & Dong, C. Antimicrobial peptides: an overview of their Structure, function and mechanism of action. Protein Pept. Lett. 29, 641\u2013650 (2022).","journal-title":"Protein Pept. Lett."},{"key":"33137_CR11","doi-asserted-by":"publisher","first-page":"104238","DOI":"10.1016\/j.micpath.2020.104238","volume":"146","author":"A Neshani","year":"2020","unstructured":"Neshani, A. et al. Antimicrobial peptides as a promising treatment option against Acinetobacter baumannii infections. Microb. Pathog. 146, 104238 (2020).","journal-title":"Microb. Pathog"},{"key":"33137_CR12","doi-asserted-by":"publisher","first-page":"107927","DOI":"10.1016\/j.micpath.2025.107927","volume":"207","author":"Y Bahrami","year":"2025","unstructured":"Bahrami, Y. et al. Antibiotic-peptide conjugates as alternatives to conventional antibiotics for treating infections caused by hospital-associated ESKAPE pathogens: A systematic review. Microb. Pathog. 207, 107927 (2025).","journal-title":"Microb. Pathog"},{"key":"33137_CR13","doi-asserted-by":"crossref","unstructured":"Yamada, N. et al. PmrAB, the two-component system of Acinetobacter baumannii, controls the phosphoethanolamine modification of lipooligosaccharide in response to metal ions. J Bacteriol 206 (2024).","DOI":"10.1128\/jb.00435-23"},{"key":"33137_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/jam.14330","volume":"128","author":"K Saipriya","year":"2020","unstructured":"Saipriya, K., Swathi, C. H., Ratnakar, K. S. & Sritharan, V. Quorum-sensing system in Acinetobacter baumannii: a potential target for new drug development. J. Appl. Microbiol. 128, 15\u201327 (2020).","journal-title":"J. Appl. Microbiol."},{"key":"33137_CR15","doi-asserted-by":"crossref","unstructured":"de Breij, A. et al. The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms. Sci Transl Med 10 (2018).","DOI":"10.1126\/scitranslmed.aan4044"},{"key":"33137_CR16","doi-asserted-by":"publisher","first-page":"26516","DOI":"10.1073\/pnas.1909585117","volume":"116","author":"J Mwangi","year":"2019","unstructured":"Mwangi, J. et al. The antimicrobial peptide ZY4 combats multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii infection. Proc. Natl. Acad. Sci. 116, 26516\u201326522 (2019).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"33137_CR17","doi-asserted-by":"crossref","unstructured":"Liu, W. et al. Antimicrobial peptide Cec4 eradicates the bacteria of clinical Carbapenem-Resistant Acinetobacter baumannii biofilm. Front Microbiol 11 (2020).","DOI":"10.3389\/fmicb.2020.01532"},{"key":"33137_CR18","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.2147\/IDR.S332051","volume":"14","author":"A Gedefie","year":"2021","unstructured":"Gedefie, A. et al. Acinetobacter baumannii biofilm formation and its role in disease pathogenesis: A review. Infect. Drug Resist. 14, 3711\u20133719 (2021).","journal-title":"Infect. Drug Resist."},{"key":"33137_CR19","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3390\/ph14070687","volume":"14","author":"KAM McMillan","year":"2021","unstructured":"McMillan, K. A. M. & Coombs, M. R. P. Investigating potential applications of the fish Anti-Microbial peptide pleurocidin: A systematic review. Pharmaceuticals 14, 687 (2021).","journal-title":"Pharmaceuticals"},{"key":"33137_CR20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.micpath.2018.11.052","volume":"127","author":"SJ Ko","year":"2019","unstructured":"Ko, S. J. et al. Antibacterial and anti-biofilm activity, and mechanism of action of pleurocidin against drug resistant Staphylococcus aureus. Microb. Pathog. 127, 70\u201378 (2019).","journal-title":"Microb. Pathog"},{"key":"33137_CR21","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.3390\/molecules27092675","volume":"27","author":"X Li","year":"2022","unstructured":"Li, X., Zuo, S., Wang, B., Zhang, K. & Wang, Y. Antimicrobial mechanisms and clinical application prospects of antimicrobial peptides. Molecules 27, 2675 (2022).","journal-title":"Molecules"},{"key":"33137_CR22","doi-asserted-by":"crossref","unstructured":"Grassi, L., Maisetta, G., Esin, S. & Batoni, G. Combination strategies to enhance the efficacy of antimicrobial peptides against bacterial biofilms. Front Microbiol 8 (2017).","DOI":"10.3389\/fmicb.2017.02409"},{"key":"33137_CR23","doi-asserted-by":"crossref","unstructured":"Xie, F. et al. Large-scale genomic analysis reveals significant role of insertion sequences in antimicrobial resistance of Acinetobacter baumannii. MBio 16 (2025).","DOI":"10.1128\/mbio.02852-24"},{"key":"33137_CR24","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2217\/fmb-2019-0322","volume":"15","author":"J Huang","year":"2020","unstructured":"Huang, J. et al. Regulating polymyxin resistance in Gram-Negative bacteria: roles of Two-Component systems PhoPQ and PmrAB. Future Microbiol. 15, 445\u2013459 (2020).","journal-title":"Future Microbiol."},{"key":"33137_CR25","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3390\/antibiotics12050813","volume":"12","author":"SY Ko","year":"2023","unstructured":"Ko, S. Y. et al. Acinetobacter baumannii under acidic conditions induces colistin resistance through PmrAB activation and lipid A modification. Antibiotics 12, 813 (2023).","journal-title":"Antibiotics"},{"key":"33137_CR26","doi-asserted-by":"crossref","unstructured":"Charretier, Y. et al. Colistin heteroresistance and involvement of the PmrAB regulatory system in Acinetobacter baumannii. Antimicrob Agents Chemother 62 (2018).","DOI":"10.1128\/AAC.00788-18"},{"key":"33137_CR27","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.3390\/ijms20071781","volume":"20","author":"AY Bhagirath","year":"2019","unstructured":"Bhagirath, A. Y. et al. Two component regulatory systems and antibiotic resistance in Gram-Negative pathogens. Int. J. Mol. Sci. 20, 1781 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"33137_CR28","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1128\/JB.01929-07","volume":"190","author":"C Niu","year":"2008","unstructured":"Niu, C., Clemmer, K. M., Bonomo, R. A. & Rather, P. N. Isolation and characterization of an autoinducer synthase from Acinetobacter baumannii. J. Bacteriol. 190, 3386\u20133392 (2008).","journal-title":"J. Bacteriol."},{"key":"33137_CR29","doi-asserted-by":"publisher","first-page":"10821","DOI":"10.3390\/ijms251910821","volume":"25","author":"P Gagat","year":"2024","unstructured":"Gagat, P., Ostr\u00f3wka, M., Duda-Madej, A. & Mackiewicz, P. Enhancing antimicrobial peptide activity through modifications of Charge, Hydrophobicity, and structure. Int. J. Mol. Sci. 25, 10821 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"33137_CR30","doi-asserted-by":"crossref","unstructured":"Bisaro, F., Shuman, H. A., Feldman, M. F., Gebhardt, M. J. & Pukatzki, S. Acinetobacter baumannii ATCC 17978 encodes a microcin system with antimicrobial properties for contact-independent competition. Microbiology 169 (2023).","DOI":"10.1099\/mic.0.001346"},{"key":"33137_CR31","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1186\/1471-2105-11-S1-S19","volume":"11","author":"S Lata","year":"2010","unstructured":"Lata, S., Mishra, N. K. & Raghava, G. P. AntiBP2: improved version of antibacterial peptide prediction. BMC Bioinform. 11, S19 (2010).","journal-title":"BMC Bioinform."},{"key":"33137_CR32","doi-asserted-by":"publisher","first-page":"D288","DOI":"10.1093\/nar\/gkaa991","volume":"49","author":"M Pirtskhalava","year":"2021","unstructured":"Pirtskhalava, M. et al. DBAASP v3: database of antimicrobial\/cytotoxic activity and structure of peptides as a resource for development of new therapeutics. Nucleic Acids Res. 49, D288\u2013D297 (2021).","journal-title":"Nucleic Acids Res."},{"key":"33137_CR33","doi-asserted-by":"crossref","unstructured":"Nobakht, M. S. et al. Investigating the antimicrobial effects of a novel peptide derived from Listeriolysin S on S aureus, E coli, and L plantarum : an in Silico and in vitro study. Bioinform Biol. Insights 18 (2024).","DOI":"10.1177\/11779322241252513"},{"key":"33137_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10989-025-10747-6","volume":"31","author":"MK Golshoui","year":"2025","unstructured":"Golshoui, M. K. et al. Assessment of the antimicrobial efficacy of a novel peptide against Porphyromonas gingivalis: an in Silico and in vitro investigation. Int. J. Pept. Res. Ther. 31, 87 (2025).","journal-title":"Int. J. Pept. Res. Ther."},{"key":"33137_CR35","doi-asserted-by":"publisher","first-page":"W432","DOI":"10.1093\/nar\/gkad376","volume":"51","author":"J Rey","year":"2023","unstructured":"Rey, J., Murail, S., de Vries, S., Derreumaux, P. & Tuffery, P. PEP-FOLD4: a pH-dependent force field for peptide structure prediction in aqueous solution. Nucleic Acids Res. 51, W432\u2013W437 (2023).","journal-title":"Nucleic Acids Res."},{"key":"33137_CR36","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1093\/bioinformatics\/btn392","volume":"24","author":"R Gautier","year":"2008","unstructured":"Gautier, R., Douguet, D., Antonny, B. & Drin, G. HELIQUEST: a web server to screen sequences with specific \u03b1-helical properties. Bioinformatics 24, 2101\u20132102 (2008).","journal-title":"Bioinformatics"},{"key":"33137_CR37","doi-asserted-by":"crossref","unstructured":"Humphries, R., Bobenchik, A. M., Hindler, J. A. & Schuetz, A. N. Overview of changes to the clinical and laboratory standards Institute performance standards for antimicrobial susceptibility Testing, M100, 31st edition. J Clin. Microbiol 59 (2021).","DOI":"10.1128\/JCM.00213-21"},{"key":"33137_CR38","first-page":"100113","volume":"8","author":"F Ahmed","year":"2023","unstructured":"Ahmed, F. et al. Effectiveness of colistin in carbapenem resistant Acinetobacter baumannii \u2013 A systematic review. Heal Sci. Rev. 8, 100113 (2023).","journal-title":"Heal Sci. Rev."},{"key":"33137_CR39","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/pathogens10020165","volume":"10","author":"B Kowalska-Krochmal","year":"2021","unstructured":"Kowalska-Krochmal, B. & Dudek-Wicher, R. The minimum inhibitory concentration of antibiotics: Methods, Interpretation, clinical relevance. Pathogens 10, 165 (2021).","journal-title":"Pathogens"},{"key":"33137_CR40","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/1469-0691.12651","volume":"20","author":"MD Macia","year":"2014","unstructured":"Macia, M. D., Rojo-Molinero, E. & Oliver, A. Antimicrobial susceptibility testing in biofilm-growing bacteria. Clin. Microbiol. Infect. 20, 981\u2013990 (2014).","journal-title":"Clin. Microbiol. Infect."},{"key":"33137_CR41","doi-asserted-by":"publisher","DOI":"10.3791\/2437","author":"GA O\u2019Toole","year":"2011","unstructured":"O\u2019Toole, G. A. Microtiter dish biofilm formation assay. J. Vis. Exp. https:\/\/doi.org\/10.3791\/2437 (2011).","journal-title":"J. Vis. Exp."},{"key":"33137_CR42","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.1128\/AAC.00372-13","volume":"57","author":"MA Orman","year":"2013","unstructured":"Orman, M. A. & Brynildsen, M. P. Establishment of a method to rapidly assay bacterial persister metabolism. Antimicrob. Agents Chemother. 57, 4398\u20134409 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"33137_CR43","doi-asserted-by":"publisher","unstructured":"Maren,N. A. et al. Stepwise optimization of Real-Time RT-PCR analysis, 317\u2013332. https:\/\/doi.org\/10.1007\/978-1-0716-3131-7_20 (2023).","DOI":"10.1007\/978-1-0716-3131-7_20"},{"key":"33137_CR44","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-3-319-16104-4_11","volume-title":"The Impact of Food Bioactives on Health","author":"D Mart\u00ednez-Maqueda","year":"2015","unstructured":"Mart\u00ednez-Maqueda, D., Miralles, B. & Recio, I. HT29 cell line. in The Impact of Food Bioactives on Health 113\u2013124 (Springer International Publishing, Cham, doi:https:\/\/doi.org\/10.1007\/978-3-319-16104-4_11. (2015)."},{"key":"33137_CR45","doi-asserted-by":"publisher","unstructured":"Pr\u00e4bst, K., Engelhardt, H., Ringgeler, S. & H\u00fcbner, H. Basic Colorimetric Proliferation Assays: MTT, WST, and Resazurin, 1\u201317. https:\/\/doi.org\/10.1007\/978-1-4939-6960-9_1 (2017).","DOI":"10.1007\/978-1-4939-6960-9_1"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33137-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33137-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33137-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:49:41Z","timestamp":1781624981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33137-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["33137"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-33137-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]},"assertion":[{"value":"30 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3226"}}